
News|Slideshows|March 27, 2025
Emerging Research and News in Prostate Cancer Imaging — March 2025
Author(s)Diagnostic Imaging Staff
Catch up on the most-well viewed prostate imaging content in March 2025.
Advertisement
Touching on a variety of topics in prostate cancer imaging, ranging from monitoring of prostate MRI exams to reduce contrast use to a new meta-analysis on AI and bpMRI for csPCa detection and FDA approval of Gozellix for the preparation of the PSMA PET agent 68Ga gozetotide, here are the top five most well-viewed prostate imaging content from Diagnostic Imaging for March 2025.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
New Imaging Platform Allows Single-Integration Access to Multiple AI Vendors
2
Is bpMRI Sufficient for Assessing PI-RADS 3 Lesions?
3
Can Contrast-Enhanced Mammography Offer a Viable Option for Pre-Op Assessment of Pathologic Nipple Involvement?
4
Fujifilm Sonosite Unveils Next-Generation Point-of-Care Ultrasound Device
5






























